Hyloris Revenue and Competitors

Liège,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Hyloris's estimated annual revenue is currently $10.3M per year.(i)
  • Hyloris's estimated revenue per employee is $201,000

Employee Data

  • Hyloris has 51 Employees.(i)
  • Hyloris grew their employee count by 6% last year.

Hyloris's People

NameTitleEmail/Phone
1
VP Regulatory StrategyReveal Email/Phone
2
VP Clinical AffairsReveal Email/Phone
3
VP Investor Relations and Corporate CommunicationsReveal Email/Phone
4
Head R&DReveal Email/Phone
5
IP DirectorReveal Email/Phone
6
Director Project ManagementReveal Email/Phone
7
Senior Manager, Regulatory StrategyReveal Email/Phone
8
Clinical Project ManagerReveal Email/Phone
9
Clinical Project ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Hyloris?

Hyloris is an early-stage innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris develops proprietary products it believes offer significant advantages compared to currently available alternatives, with the aim to address the underserved medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system. Hyloris' portfolio spans three areas of focus: IV Cardiovascular, Other Reformulations and Established Market (high-barrier generics).

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hyloris News

2022-04-13 - Hyloris Raises €15m In Private Equity Offering

Value-added medicines firm Hyloris has raised €15m from new and existing investors through a private equity offering of nearly one million...

2022-03-30 - Hyloris Successfully Raises EUR 15.0 Million in an Equity ...

Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare...

2022-03-22 - Hyloris Launches Equity Offering by Means of a Private ...

LIÈGE, Belgium, March 31, 2022 (GLOBE NEWSWIRE) -- Hyloris Pharmaceuticals SA (Euronext Brussels: HYL) (the “Company” or “Hyloris”), a specialty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M832%N/A
#2
$34.2M1484%N/A
#3
$123.8M45017%N/A
#4
$102.6M6628%N/A
#5
$203.4M8359%N/A